Biocept Inc (BIOC)

Biocept (BIOC) Stock Price & Analysis


BIOC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.80 - $28.52
Previous Close$1.35
Average Volume (3M)1.91M
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$6.60M
Total Debt (Recent Filing)$11.06M
Price to Earnings (P/E)>-0.1
Nov 15, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-39.28
Shares Outstanding2,626,026
10 Day Avg. Volume316,756
30 Day Avg. Volume1,908,683
Standard Deviation0.36
Financial Highlights & Ratios
Price to Book (P/B)12.22
Price to Sales (P/S)6.04
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Biocept Inc’s price range in the past 12 months?
Biocept Inc lowest stock price was $0.80 and its highest was $28.52 in the past 12 months.
    What is Biocept Inc’s market cap?
    Currently, no data Available
    When is Biocept Inc’s upcoming earnings report date?
    Biocept Inc’s upcoming earnings report date is Nov 15, 2023 which is in 46 days.
      How were Biocept Inc’s earnings last quarter?
      Biocept Inc released its earnings results on Aug 14, 2023. The company reported -$3.5 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.5.
        Is Biocept Inc overvalued?
        According to Wall Street analysts Biocept Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Biocept Inc pay dividends?
          Biocept Inc does not currently pay dividends.
          What is Biocept Inc’s EPS estimate?
          Biocept Inc’s EPS estimate is -$2.36.
            How many shares outstanding does Biocept Inc have?
            Biocept Inc has 2,626,026 shares outstanding.
              What happened to Biocept Inc’s price movement after its last earnings report?
              Biocept Inc reported an EPS of -$3.5 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.636%.
                Which hedge fund is a major shareholder of Biocept Inc?
                Among the largest hedge funds holding Biocept Inc’s share is Hussman Strategic Advisors Inc. It holds Biocept Inc’s shares valued at N/A.


                  Biocept Stock Smart Score

                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Biocept Inc

                  Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.


                  Top 5 ETFs holding BIOC

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold BIOC. The ETFs are listed according to market value of BIOC within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  BioNano Genomics
                  Bio-Path Holdings
                  China Pharma Holdings

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis